New start-up buys Solianis assets

Please login or
register
25.10.2011

Biovotion acquires Solinianis IP and sensor infrastructure. The new start-up, based in the Technopark Zurich, develops technology and products for the continuous non-invasive monitoring of physiologic and metabolic processes.

Biovotion has finalised the acquisition of the Solianis sensors and their related relevant technical infrastructure. This acquisition presents new business opportunities when combined with the recent acquisition of the entire Solianis IP portfolio. The full availability of IP and technology will allow Biovotion to continue unfolding its activities within the field of physiological monitoring. Solianis, a Swiss Medtech company that was founded in 2005 and went bankrupt some month ago, was also active in this field.

The availability of this IP portfolio and the respective sensors allows Biovotion to consider expanding the physiological monitoring platform. Biovotion can also directly benefit from previously established technology and know-how combined with the now readily available sensor technology and software.

Biovotion’s know-how and business opportunities

Within the scientific and engineering fields, Biovotion covers areas such as biophysics, dielectrics, optics, software, evaluation of complex data or physiological processes and their biophysical implications.

Within the market/application fields, this includes expertise on the development of highly portable wearable devices, their respective regulatory requirements, sophisticated technical ICT environments, design, set up and execution of experiment/clinical studies.

Biovotion’s VSM platform

In a first step, Biovotion is working on a vital sign monitoring (VSM) application for non-invasive physiological monitoring of blood circulation parameters. Biovotion’s VSM platform will be highly portable and can be easily worn to enable continuous monitoring of various global and local vital sign parameters like heart rate, arterial and venous blood oxygenation or respiration rate.

0Comments

More news about

Biovotion AG

Company profiles on startup.ch

Biovotion AG

rss